1500 patients join quest to decode bronchiectasis in china

NCT ID NCT06900062

Recruiting now Knowledge-focused Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to better understand bronchiectasis, a chronic lung disease, in Chinese patients. Researchers will collect data from 1500 adults to identify different disease types and their underlying causes. The goal is to improve diagnosis and tailor treatments for each patient. No experimental drugs or treatments are being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic bronchopulmonary aspergillosis bronchiectasis cystic fibrosis primary ciliary dyskinesia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHIECTASIS ADULT

Contacts and locations

Locations

He-feng Chen
RECRUITING

Shanghai, Shanghai Municipality, 200433, China
Jun She
RECRUITING

Shanghai, Shanghai Municipality, 200437, China
Lei Song
RECRUITING

Changchun, Jilin, China
Lin Liu
RECRUITING

Guiyang, Guizhou, China
Qian Qi
RECRUITING

Jinan, Shangdong, China
Xiao-long Ma
RECRUITING

Jiaxing, Zhejiang, China
Xue-ling Wu
RECRUITING

Shanghai, Shanghai Municipality, 200437, China
Yong-hua Gao
RECRUITING

Shanghai, Shanghai Municipality, 200437, China
Zhou-fang Mei
RECRUITING

Shanghai, Shanghai Municipality, 200433, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.